137 related articles for article (PubMed ID: 36346064)
21. Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: A prospective cohort study.
Podlipnik S; Carrera C; Sánchez M; Arguis P; Olondo ML; Vilana R; Rull R; Vidal-Sicart S; Vilalta A; Conill C; Malvehy J; Puig S
J Am Acad Dermatol; 2016 Sep; 75(3):516-524. PubMed ID: 27183845
[TBL] [Abstract][Full Text] [Related]
22. Sentinel Node Status is the Most Important Prognostic Information for Clinical Stage IIB and IIC Melanoma Patients.
Fonseca IB; Lindote MVN; Monteiro MR; Doria Filho E; Pinto CAL; Jafelicci AS; de Melo Lôbo M; Calsavara VF; Bertolli E; Duprat Neto JP
Ann Surg Oncol; 2020 Oct; 27(11):4133-4140. PubMed ID: 32767223
[TBL] [Abstract][Full Text] [Related]
23. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma JM; Deneve JL; Fleming MD; Perez MC; Lowe MC; Olofsson Bagge R; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley G; Hui JYC; Been L; Kruijff S; Kim Y; Naqvi SMH; Sarnaik AA; Sondak VK; Zager JS
Cancer; 2021 Jul; 127(13):2251-2261. PubMed ID: 33826754
[TBL] [Abstract][Full Text] [Related]
24. Patient-reported outcomes in patients with resected, high-risk melanoma with BRAF
Schadendorf D; Hauschild A; Santinami M; Atkinson V; Mandalà M; Chiarion-Sileni V; Larkin J; Nyakas M; Dutriaux C; Haydon A; Robert C; Mortier L; Lesimple T; Plummer R; Schachter J; Dasgupta K; Manson S; Koruth R; Mookerjee B; Kefford R; Dummer R; Kirkwood JM; Long GV
Lancet Oncol; 2019 May; 20(5):701-710. PubMed ID: 30928620
[TBL] [Abstract][Full Text] [Related]
25. Follow-up schedules after treatment for malignant melanoma.
Francken AB; Accortt NA; Shaw HM; Colman MH; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
Br J Surg; 2008 Nov; 95(11):1401-7. PubMed ID: 18844268
[TBL] [Abstract][Full Text] [Related]
26. Pembrolizumab for the adjuvant treatment of IIB or IIC melanoma.
Rutkowski P; Czarnecka AM
Expert Rev Anticancer Ther; 2023; 23(9):897-902. PubMed ID: 37573515
[TBL] [Abstract][Full Text] [Related]
27. Patterns of recurrence and retreatment outcomes among clinical stage I and II head and neck melanoma patients.
Namin AW; Cornell GE; Thombs LA; Zitsch RP
Head Neck; 2019 May; 41(5):1304-1311. PubMed ID: 30629324
[TBL] [Abstract][Full Text] [Related]
28. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.
Seegenschmiedt MH; Keilholz L; Altendorf-Hofmann A; Urban A; Schell H; Hohenberger W; Sauer R
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):607-18. PubMed ID: 10348291
[TBL] [Abstract][Full Text] [Related]
29. Surgery and adjuvant radiotherapy for cutaneous melanoma considered high-risk for local-regional recurrence.
Mendenhall WM; Shaw C; Amdur RJ; Kirwan J; Morris CG; Werning JW
Am J Otolaryngol; 2013; 34(4):320-2. PubMed ID: 23375588
[TBL] [Abstract][Full Text] [Related]
30. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.
Abu-Rustum NR; Restivo A; Ivy J; Soslow R; Sabbatini P; Sonoda Y; Barakat RR; Chi DS
Gynecol Oncol; 2006 Oct; 103(1):31-4. PubMed ID: 16537089
[TBL] [Abstract][Full Text] [Related]
31. Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma.
Mo DC; Huang JF; Luo PH; Chen L; Huang SX
Lancet Oncol; 2023 Jan; 24(1):e7. PubMed ID: 36603930
[No Abstract] [Full Text] [Related]
32. The value of lymph node ultrasound and whole body
Stahlie EHA; van der Hiel B; Bruining A; van de Wiel B; Schrage YM; Wouters MWJM; van Houdt WJ; van Akkooi ACJ
Eur J Surg Oncol; 2021 May; 47(5):1157-1162. PubMed ID: 33353826
[TBL] [Abstract][Full Text] [Related]
33. Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.
Slingluff CL; Lewis KD; Andtbacka R; Hyngstrom J; Milhem M; Markovic SN; Bowles T; Hamid O; Hernandez-Aya L; Claveau J; Jang S; Philips P; Holtan SG; Shaheen MF; Curti B; Schmidt W; Butler MO; Paramo J; Lutzky J; Padmanabhan A; Thomas S; Milton D; Pecora A; Sato T; Hsueh E; Badarinath S; Keech J; Kalmadi S; Kumar P; Weber R; Levine E; Berger A; Bar A; Beck JT; Travers JB; Mihalcioiu C; Gastman B; Beitsch P; Rapisuwon S; Glaspy J; McCarron EC; Gupta V; Behl D; Blumenstein B; Peterkin JJ
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599031
[TBL] [Abstract][Full Text] [Related]
34. Improved survival of patients with stage II melanoma of the extremity using hyperthermic isolation perfusion with 1-phenylalanine mustard.
Hartley JW; Fletcher WS
J Surg Oncol; 1987 Nov; 36(3):170-4. PubMed ID: 3682836
[TBL] [Abstract][Full Text] [Related]
35. Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma - Authors' reply.
Long GV; Luke JJ; Fukunaga-Kalabis M; Ascierto PA
Lancet Oncol; 2023 Jan; 24(1):e8. PubMed ID: 36603931
[No Abstract] [Full Text] [Related]
36. [Locally recurrent and metastatic malignant melanoma. Long-term results and prognostic factors after percutaneous radiotherapy].
Seegenschmiedt MH; Keilholz L; Pieritz A; Altendorf-Hofmann A; Urban A; Schell H; Hohenberger W; Sauer R
Strahlenther Onkol; 1999 Sep; 175(9):450-7. PubMed ID: 10518979
[TBL] [Abstract][Full Text] [Related]
37. Considering adjuvant therapy for stage II melanoma.
Poklepovic AS; Luke JJ
Cancer; 2020 Mar; 126(6):1166-1174. PubMed ID: 31869447
[TBL] [Abstract][Full Text] [Related]
38. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II).
Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
Ann Surg; 1981 Mar; 193(3):377-88. PubMed ID: 7212800
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Prostate Cancer Stage Groups Updated in the 8th Edition of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging Manual.
Lee H; Lee M; Byun SS; Lee SE; Hong SK
Clin Genitourin Cancer; 2019 Feb; 17(1):e221-e226. PubMed ID: 30472041
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]